Skip to main content

Safety and efficacy of AK0529 in respiratory syncytial virus‐infected infant patients: A phase 2 proof‐of‐concept trial.

Influenza and other respiratory viruses,

Huang, L.M., Schibler, A., Huang, Y.C., Tai, A., Chi, H., Chieng, C.H., Wang, J.L., Goldbart, A., Tang, S.P., Huang, Y.C. and George, S., 2023. Safety and efficacy of AK0529 in respiratory syncytial virus‐infected infant patients: A phase 2 proof‐of‐concept trial. Influenza and other respiratory viruses, 17(7), p.e13176.


Last updated 19 Feb 2024